0001127602-20-010908.txt : 20200316
0001127602-20-010908.hdr.sgml : 20200316
20200316181135
ACCESSION NUMBER: 0001127602-20-010908
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200316
DATE AS OF CHANGE: 20200316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calcaterra Chris M.
CENTRAL INDEX KEY: 0001640771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 20718587
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 26051 MERIT CIRCLE, SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-03-12
0001192448
GLAUKOS Corp
GKOS
0001640771
Calcaterra Chris M.
C/O GLAUKOS CORPORATION
229 AVENIDA FABRICANTE
SAN CLEMENTE
CA
92672
1
Chief Operating Officer
Common Stock
2020-03-12
4
A
0
647
0
A
159309
D
Stock Option (Right to Buy)
39.10
2020-03-12
4
A
0
51769
0
A
2030-03-12
Common Stock
51769
51769
D
Represents shares of common stock subject to a restricted stock unit award previously granted by the Issuer on April 1, 2019 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2019 in the form of restricted stock units rather than cash (the "Bonus Election"). The Compensation Committee determined on March 12, 2020 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2019 executive bonus plan and the number of stock units earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date. The restricted stock units will vest on April 1, 2020 and are payable on a one-for-one basis in shares of the Issuer's common stock.
Includes 6,311 restricted stock units that have not yet vested or been delivered to the Reporting Person.
These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
/s/ Robert L. Davis, Attorney-in-Fact
2020-03-16